Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways

Molecular Pharmacology

Volumn 53, Issue 1, 1998, Pages 1-5

  Nishizaki, Tomoyuki ^a   Matsuoka, Toshiyuki ^a   Nomura, Tamotsu ^a   Sumikawa, Katumi ^b   Shiotani, Tadashi ^c   Watabe, Shigeo ^c   Yoshii, Mitsunobu ^d  

^a KOBE UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DAIICHI SANKYO CO   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; NEFIRACETAM; NOOTROPIC AGENT; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; DRUG MECHANISM; ENZYME ACTIVATION; MEMBRANE CURRENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TORPEDO CALIFORNICA; XENOPUS LAEVIS;

EID: 0031914452     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.1.1     Document Type: Article

References (22)

1. Exon JH (1994) Phosphatidylcholine breakdown and signal transduction. Biophys Acta 1212: 26-42.
2. Eusebi F, Grassi F, Nervi C, Caporale C, Adamo S, Zani BM, and Molinaro M (1987) Acetylcholine may regulate its own nicotinic receptor-channel through the C-kinase system. Proc R Soc Lond B Biol Sci 230:355-365.
3. Funk KF and Schmidt J (1984) Changes of dopamine metabolism by hypoxia and effect of nootropic drugs. Biomed Biochem Acta 11:1301-1304.
4. Gehle VM and Sumikawa K (1991) Site-directed mutagenesis of the conserved N-glycosylation site on the nicotinic acetylcholine receptor subunits. Mol Brain Res 11:17-25.
5. Gouliaev AH and Senning A (1994) Piracetam and other structurally related nootropics. Brain Res Rev 19:180-222.
6. Heikkila J, Jalava A, and Eriksson K (1993) The selective protein kinase C inhibitor GF109203X inhibits phorbol ester induced morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Biochem Biophys Res Commun 197:1185-1193.
7. A receptor-channel complex in dorsal root ganglion neurons. Neuropharmacol 35:1251-1261.
8. Huganir RL (1987) Regulation of the nicotinic acetylcholine receptor by protein phosphorylation. J Recept Res 7:241-256.
9. Huganir RL and Greengard P (1990) Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron 5:555-567.
10. Isaascon J and Nicoll R (1991) Aniracetam reduces glutamate desensitization and shows the decay of fast excitatory synaptic currents in the hippocampus. Proc Natl Acad Sci USA 88:10936-10940.
11. Ito I, Tanabe S, Kohda A, and Sugiyama H (1990) Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J Physiol 424:533-543.
12. Liscovitch M and Cantley LC (1994) Lipid second messengers. Cell 77:329-334.
13. Marchi M, Besana E, and Raiteri M (1990) Oxiracetam increases the release of endogenous glutamate from depolarized rat hippocampal slices. Eur J Pharmacol 185:247-249.
14. Miledi R and Parker I (1984) Chloride current induced by injection of calcium into Xenopus oocytes. J Physiol 357:173-183.
15. Nishizaki T and Ikeuchi Y (1995) Activation of endogenous protein kinase C enhances currents through α1 and α2 glycine receptor channels. Brain Res 687:214-216.
16. Nishizuka Y (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484-496.
17. Satoh M, Ishihara K, Iwama T, and Takagi H (1986) Aniracetam augments, and midazolam inhibits, the long-term potentiation in guinea-pig hippocampal slices. Neurosci Lett 68:216-220.
18. Spignoli G and Pepeu G (1987) Interactions between oxiracetam, qaniracetam and scopolamine on behavior and brain acetylcholine. Pharmacol Biochem Behav 27: 491-495.
19. Sumikawa K and Miledi R (1989) Assembly and N-glycosylation of all ACh receptor subunits are required for their efficient insertion into plasma membranes. Mol Brain Res 5:183-192.
20. Tang C-M, Shi Q-Y, Katchman A, and Lynch G (1991) Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam. Science (Washington DC) 254:288-290.
21. Watabe S, Yamaguchi H, and Ashida S (1993) DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex. J Pharmacol 238:303-309.
22. Yoshii M and Watabe S (1994) Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells. Brain Res 642:123-131.